Treatment of Striae Distensae With Fractional Radiofrequency and Topical Tretinoin

Exclusion Criteria

• •1. Severe concurrent conditions such as cardiac disorders or poorly regulated diabetes
• •2. History of skin disorders such as keloids, abnormal wound healing or very fragile skin
• •3. History of heat-stimulated disease such as herpes simplex in the treatment area
• •4. History of bleeding coagulopathies or use of anti-coagulants
• •5. Surgery in the treatment area past 6 months or before complete healing
• •6. Tattoo or permanent make-up in treatment area
• •7. Excessively tanned skin from sun, tanning bed or tanning creams last 2 weeks
• •8. Dermabrasion, resurfacing, soft tissue/fat injections or chemical peeling in treatment area the past 3 months
• •9. Abnormal skin (e.g. rash, infection, dermatitis) at the treatment area at the time of inclusion
• •10. Treatment with Isotretinoin within the past 6 months
• •11. Use of non-steroidal anti-inflammatory drugs 1 week prior to treatment
• •12. Known allergies to tretinoin or lidocaine/prilocaine
• •13. History of cancer including pre-malignant moles
• •14. Impaired immune system due to immunosuppressive disease or medication
• •15. Electronic device implant
• •16. Any implantable metal piece or permanent chemical substance in treatment area
• •17. If female; lactating, pregnant or planning on becoming pregnant during the study
• •18. Non-eligibility at the discretion of the investigator